Home » MedicineLodge, Inc. Announces Expansion of Contract Manufacturing Services
MedicineLodge, Inc. Announces Expansion of Contract Manufacturing Services
Prnewswire.com (Associated Press)
Pharmamanufacturing.com.
07/11/2006
Medicine Lodge's expanded contract manufacturing services to meet the needs of customers looking for delivery of smaller quantity lots. The company is an FDA registered facility that is ISO 13485 and FDA QSR compliant. The company's capabilities, includes: 5 axis milling, multi-spindle turning and milling, Swiss-style screw machining, wire EDM, injection molding, welding, finishing, passivation, ultrasonic cleaning, and product marking.
"Contract manufacturing is a natural extension of our product development business," stated Wade Fallin, President and CEO of MedicineLodge, Inc. Fallin continued, "We have routinely supplied initial launch quantities of product to our development partners to speed the concept to market cycle. With our recent expansion, we can now offer our comprehensive contract manufacturing services to other medical device companies."
MedicineLodge's said that it operates 24 hours a day, and its contract manufacturing team is committed to fulfilling delivery schedules. Using its finite capacity enterprise resource planning and scheduling system, the company provides accurate product delivery dates to its customers. For customers interested in quicker turnaround, the company's On-Demand Manufacturing(TM) program offers manufacturing service contracts designed specifically to minimize lead times and maximize access.
About MedicineLodge
MedicineLodge, Inc., founded in 2000, partners with physicians, venture capital firms and corporations to develop medical devices that improve patient outcomes. The company provides comprehensive product development and manufacturing services and innovative technology solutions to the medical device industry.
More News:
- 03/12/2010 AstraZeneca Job Cuts Reflect New Landscape For Drug InnovationFrom FT.com
- 03/10/2010 Novartis Goes Wireless for Process and Plant Info
- 03/10/2010 Concerns Raised about Tromethamine ContaminationFrom Rx-360
- 03/09/2010 Pittcon 2010: Thermo Fisher Scientific Continues in Growth Mode
- 03/09/2010 Conference Report: Maintenance Is Not a Necessary Evil
- 03/05/2010 Glaxo Could Face $6bn Avandia Liability, Says UBSFrom Guardian.co.uk
- 03/05/2010 Planned Job Cuts Drop 41%; 16% for Pharma Industry
- 03/04/2010 AstraZeneca Shuffles, Eliminates Del. R&D Jobs
- 03/03/2010 Germany's Merck to Acquire MilliporeFrom NYTimes.com
- 03/03/2010 FDA Releases Final Guidance on Characterization of Cell Substrates and Bio Materials for Viral Vaccines
- All news »
Get Connected Now!
- Featured White Papers

Print page